Trials
Search / Trial NCT05657119

Family Safety Net - Aim 3: Randomized Control Trial

Launched by UNIVERSITY OF MICHIGAN · Dec 9, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Active, not recruiting

Keywords

Motivational Interviewing Suicide Prevention Alaska Native Firearm Storage Family Engagement

ClinConnect Summary

The primary goal of this parallel-group clinical trial is to test the Family Safety Net (FSN) intervention in a primarily Alaska Native population in NW Alaska. The main question\[s\] it aims to answer are:

* Is the Family Safety Net (FSN) intervention acceptable in two formats, motivational interviewing counseling session, and scripted psychoeducational session, with a primarily Alaska Native population in Northwest Alaska?
* Secondarily, our small trial will describe signals of efficacy in improving home safe storage of firearms (unloaded, locked with ammunition separate from firearms) a...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Adults (over 18) who:
  • • lives in the region,
  • • Read and Understand English,
  • • Live in a household with at least one gun,
  • • Have a phone that can receive texts,
  • • Lives in a household where young people (under 29) spend time
  • Exclusion Criteria:
  • • Someone else in the household has already participated in the study

Trial Officials

Lisa M Wexler, PhD, MSW

Principal Investigator

University of Michigan

About University Of Michigan

The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.

Locations

Kotzebue, Alaska, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials